Related references
Note: Only part of the references are listed.PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy
Mincheng Yu et al.
JOURNAL OF HEPATOLOGY (2022)
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma
Margherita Correnti et al.
LIVER INTERNATIONAL (2022)
Squamous Cell Carcinoma Antigen: Clinical Application and Research Status
Huange Zhu
DIAGNOSTICS (2022)
SerpinB3 drives cancer stem cell survival in glioblastoma
Adam Lauko et al.
CELL REPORTS (2022)
Semisolid Wet Sol-Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
Mattia Albiero et al.
PHARMACEUTICS (2022)
Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1
Wan-ting Zhang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Immune checkpoints in the tumor microenvironment
Salman M. Toor et al.
SEMINARS IN CANCER BIOLOGY (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
Biomarkers for the Early Detection of Hepatocellular Carcinoma
Neehar D. Parikh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
The clinical value of serum squamous cell carcinoma 1 and 2 in head and neck squamous cell carcinoma
Ryuji Yasumatsu et al.
AURIS NASUS LARYNX (2019)
Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
Cristian Turato et al.
CANCER SCIENCE (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy
Long Jia et al.
CANCER BIOLOGY & MEDICINE (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
Matteo Fassan et al.
ONCOTARGET (2017)
SERPINB3 and B4: From biochemistry to biology
Yu Sun et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
SerpinB3 upregulates the Cyclooxygenase-2/β-Catenin positive loop in colorectal cancer
Liliana Terrin et al.
ONCOTARGET (2017)
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges
Yael Diesendruck et al.
DRUG RESISTANCE UPDATES (2017)
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
Alessandra Biasiolo et al.
DIGESTIVE AND LIVER DISEASE (2016)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer
Ryusuke Imai et al.
ACTA OTO-LARYNGOLOGICA (2015)
Overexpression of Squamous Cell Carcinoma Antigen 1 Is Associated with the Onset and Progression of Human Hepatocellular Carcinoma
Jiao Liu et al.
ARCHIVES OF MEDICAL RESEARCH (2015)
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Martina Montagnana et al.
CLINICA CHIMICA ACTA (2015)
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
Tim F. Greten et al.
GUT (2015)
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity
Cristian Turato et al.
SCIENTIFIC REPORTS (2015)
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
C. Turato et al.
BRITISH JOURNAL OF CANCER (2014)
SCCA1/SERPINB3 Promotes Oncogenesis and Epithelial-Mesenchymal Transition via the Unfolded Protein Response and IL6 Signaling
Namratha Sheshadri et al.
CANCER RESEARCH (2014)
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
Gianluigi Giannelli et al.
GUT (2014)
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4
Joseph M. Catanzaro et al.
NATURE COMMUNICATIONS (2014)
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I
Francesco Ciscato et al.
ONCOTARGET (2014)
Squamous cell carcinoma antigen 1 and 2 mRNA and a new variant expressed in hepatocellular carcinoma
S. Li et al.
NEOPLASMA (2014)
IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
Alessandra Biasiolo et al.
PLOS ONE (2012)
Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD
Cristian Turato et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Squamous Cell Carcinoma Antigen 1 Promotes Caspase-8-Mediated Apoptosis in Response to Endoplasmic Reticulum Stress While Inhibiting Necrosis Induced by Lysosomal Injury
Erica Ullman et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma
Joseph M. Catanzaro et al.
PLOS ONE (2011)
SERPINB3 induces epithelial-mesenchymal transition
Santina Quarta et al.
JOURNAL OF PATHOLOGY (2010)
Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family
K. Izuhara et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer
K. -F. Hsu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer
T. Oshikiri et al.
CANCER GENE THERAPY (2006)
Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase
C Katagiri et al.
JOURNAL OF CELL BIOLOGY (2006)
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma
L Beneduce et al.
CANCER (2005)
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma
P Pontisso et al.
BRITISH JOURNAL OF CANCER (2004)
Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis
GA Silverman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus
DJ Askew et al.
GENOMICS (2004)
Serpin structure, mechanism, and function
PGW Gettins
CHEMICAL REVIEWS (2002)
The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases
M Al-Khunaizi et al.
BIOCHEMISTRY (2002)
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins - Evolution, mechanism of inhibition, novel functions, and a revised nomenclature
GA Silverman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The 5,6-and 4,5-benzo derivatives of 1-hydroxy-7-azabenzotriazole
LA Carpino et al.
ORGANIC LETTERS (2001)
Squamous cell carcinoma antigen suppresses radiation-induced cell death
A Murakami et al.
BRITISH JOURNAL OF CANCER (2001)
Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas
S Cataltepe et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
Share Paper
